{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:38:02Z","timestamp":1788781082286,"version":"build-2803163510"},"reference-count":65,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2020,10,1]]},"DOI":"10.1001\/jamaneurol.2020.1948","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T15:43:19Z","timestamp":1594050199000},"page":"1279","source":"Crossref","is-referenced-by-count":58,"title":["Prognosis of Cryptogenic Stroke With Patent Foramen Ovale at Older Ages and Implications for Trials"],"prefix":"10.1001","volume":"77","author":[{"given":"Sara","family":"Mazzucco","sequence":"first","affiliation":[{"name":"Wolfson Centre for Prevention of Stroke and Dementia, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linxin","family":"Li","sequence":"additional","affiliation":[{"name":"Wolfson Centre for Prevention of Stroke and Dementia, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Rothwell","sequence":"additional","affiliation":[{"name":"Wolfson Centre for Prevention of Stroke and Dementia, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"12","key":"noi200042r1","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","article-title":"Closure of patent foramen ovale versus medical therapy after cryptogenic stroke.","volume":"368","author":"Carroll","year":"2013","journal-title":"N Engl J Med"},{"issue":"11","key":"noi200042r2","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","article-title":"Long-term outcomes of patent foramen ovale closure or medical therapy after stroke.","volume":"377","author":"Saver","year":"2017","journal-title":"N Engl J Med"},{"issue":"11","key":"noi200042r3","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","article-title":"Patent foramen ovale closure or anticoagulation vs antiplatelets after stroke.","volume":"377","author":"Mas","year":"2017","journal-title":"N Engl J Med"},{"issue":"11","key":"noi200042r4","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","article-title":"Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke.","volume":"377","author":"S\u00f8ndergaard","year":"2017","journal-title":"N Engl J Med"},{"issue":"20","key":"noi200042r5","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.jacc.2018.02.046","article-title":"Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO Trial.","volume":"71","author":"Lee","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"noi200042r6","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(18)30167-4","article-title":"Prevalence of patent foramen ovale in cryptogenic transient ischaemic attack and non-disabling stroke at older ages: a population-based study, systematic review, and meta-analysis.","volume":"17","author":"Mazzucco","year":"2018","journal-title":"Lancet Neurol"},{"issue":"22","key":"noi200042r7","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1056\/NEJMoa071422","article-title":"Patent foramen ovale and cryptogenic stroke in older patients.","volume":"357","author":"Handke","year":"2007","journal-title":"N Engl J Med"},{"issue":"12","key":"noi200042r8","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008356","article-title":"Closure, anticoagulation, or antiplatelet therapy for cryptogenic stroke with patent foramen ovale: systematic review of randomized trials, sequential meta-analysis, and new insights from the CLOSE Study.","volume":"7","author":"Turc","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"noi200042r9","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1161\/01.STR.0000135773.24116.18","article-title":"Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale.","volume":"35","author":"Homma","year":"2004","journal-title":"Stroke"},{"issue":"9425","key":"noi200042r10","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0140-6736(04)16405-2","article-title":"Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study).","volume":"363","author":"Rothwell","year":"2004","journal-title":"Lancet"},{"issue":"9","key":"noi200042r11","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S1474-4422(15)00132-5","article-title":"Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study.","volume":"14","author":"Li","year":"2015","journal-title":"Lancet Neurol"},{"issue":"6","key":"noi200042r12","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1159\/000016119","article-title":"Detection of right-to-left shunt with ultrasound contrast agent and transcranial Doppler sonography.","volume":"10","author":"Jauss","year":"2000","journal-title":"Cerebrovasc Dis"},{"issue":"8","key":"noi200042r13","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1161\/STROKEAHA.106.479485","article-title":"Diagnosis of right-to-left shunt with transcranial Doppler and vertebrobasilar recording.","volume":"38","author":"Del Sette","year":"2007","journal-title":"Stroke"},{"issue":"1","key":"noi200042r14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial: TOAST, Trial of Org 10172 in Acute Stroke Treatment.","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"key":"noi200042r15","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"issue":"8","key":"noi200042r16","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1747-4949.2012.00843.x","article-title":"The Risk of Paradoxical Embolism (RoPE) Study: initial description of the completed database.","volume":"8","author":"Thaler","year":"2013","journal-title":"Int J Stroke"},{"issue":"5","key":"noi200042r17","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/0002-8703(95)90212-0","article-title":"Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack.","volume":"130","author":"Mas","year":"1995","journal-title":"Am Heart J"},{"issue":"4","key":"noi200042r18","first-page":"80","article-title":"Assessing the quality of studies in meta-analyses: advantages and limitations of the Newcastle Ottawa Scale.","volume":"5","author":"Luchini","year":"2017","journal-title":"World J Metaanal"},{"issue":"1-2","key":"noi200042r21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000492820","article-title":"Impact of the ageing population on the burden of stroke: the Dijon Stroke Registry.","volume":"52","author":"B\u00e9jot","year":"2019","journal-title":"Neuroepidemiology"},{"issue":"4","key":"noi200042r22","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1080\/00015385.2017.1307668","article-title":"Clinical outcomes of secondary prevention strategies for young patients with cryptogenic stroke and patent foramen ovale.","volume":"72","author":"Danese","year":"2017","journal-title":"Acta Cardiol"},{"issue":"3","key":"noi200042r23","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s00415-018-8742-x","article-title":"Impact of D-dimer levels for short-term or long-term outcomes in cryptogenic stroke patients.","volume":"265","author":"Nezu","year":"2018","journal-title":"J Neurol"},{"issue":"4","key":"noi200042r24","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000229553","article-title":"Current management and risk of recurrent stroke in cerebrovascular patients with right-to-left cardiac shunt.","volume":"28","author":"Weimar","year":"2009","journal-title":"Cerebrovasc Dis"},{"issue":"20","key":"noi200042r25","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJMoa1813959","article-title":"Dabigatran for prevention of stroke after embolic stroke of undetermined source.","volume":"380","author":"Diener","year":"2019","journal-title":"N Engl J Med"},{"issue":"12","key":"noi200042r26","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","article-title":"Percutaneous closure of patent foramen ovale in cryptogenic embolism.","volume":"368","author":"Meier","year":"2013","journal-title":"N Engl J Med"},{"issue":"11","key":"noi200042r27","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1009639","article-title":"Closure or medical therapy for cryptogenic stroke with patent foramen ovale.","volume":"366","author":"Furlan","year":"2012","journal-title":"N Engl J Med"},{"issue":"12","key":"noi200042r28","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S1474-4422(18)30319-3","article-title":"Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.","volume":"17","author":"Kasner","year":"2018","journal-title":"Lancet Neurol"},{"issue":"24","key":"noi200042r29","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJMoa011503","article-title":"Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both.","volume":"345","author":"Mas","year":"2001","journal-title":"N Engl J Med"},{"issue":"12","key":"noi200042r30","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1161\/STROKEAHA.108.521427","article-title":"Recurrent stroke and massive right-to-left shunt: results from the prospective Spanish multicenter (CODICIA) study.","volume":"39","author":"Serena","year":"2008","journal-title":"Stroke"},{"issue":"3","key":"noi200042r31","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3349\/ymj.2016.57.3.621","article-title":"Comparison of outcomes after device closure and medication alone in patients with patent foramen ovale and cryptogenic stroke in Korean population.","volume":"57","author":"Moon","year":"2016","journal-title":"Yonsei Med J"},{"issue":"2","key":"noi200042r32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000321334","article-title":"Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.","volume":"31","author":"Paciaroni","year":"2011","journal-title":"Cerebrovasc Dis"},{"issue":"1","key":"noi200042r33","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00415-012-6629-9","article-title":"Management of right-to-left shunt in cryptogenic cerebrovascular disease: results from the observational Austrian Paradoxical Cerebral Embolism Trial (TACET) registry.","volume":"260","author":"Horner","year":"2013","journal-title":"J Neurol"},{"issue":"1","key":"noi200042r34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1017\/S0317167100004674","article-title":"Stroke recurrence and its prevention in patients with patent foramen ovale.","volume":"33","author":"Harrer","year":"2006","journal-title":"Can J Neurol Sci"},{"issue":"1","key":"noi200042r35","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.amjcard.2010.02.025","article-title":"Association between anatomic features of atrial septal abnormalities obtained by omni-plane transesophageal echocardiography and stroke recurrence in cryptogenic stroke patients with patent foramen ovale.","volume":"106","author":"Lee","year":"2010","journal-title":"Am J Cardiol"},{"issue":"6","key":"noi200042r36","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1161\/CIRCULATIONAHA.111.030494","article-title":"Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism.","volume":"125","author":"Wahl","year":"2012","journal-title":"Circulation"},{"issue":"1","key":"noi200042r37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijcard.2004.03.005","article-title":"Secondary prevention after cryptogenic cerebrovascular events in patients with patent foramen ovale.","volume":"101","author":"Schuchlenz","year":"2005","journal-title":"Int J Cardiol"},{"issue":"1","key":"noi200042r38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1017\/S0317167100005825","article-title":"Recurrent stroke\/TIA in cryptogenic stroke patients with patent foramen ovale.","volume":"34","author":"Casaubon","year":"2007","journal-title":"Can J Neurol Sci"},{"issue":"2","key":"noi200042r39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1046\/j.1468-1331.2003.00561.x","article-title":"Transcranial Doppler and risk of recurrence in patients with stroke and patent foramen ovale.","volume":"10","author":"Anzola","year":"2003","journal-title":"Eur J Neurol"},{"issue":"6","key":"noi200042r40","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10072-006-0524-z","article-title":"Recurrent cerebrovascular ischaemic events in patients with interatrial septal abnormalities: a follow-up study.","volume":"26","author":"Cerrato","year":"2006","journal-title":"Neurol Sci"},{"issue":"1","key":"noi200042r41","first-page":"57","article-title":"Prevention of recurrent cerebral ischemic events in patients with patent foramen ovale and cryptogenic strokes or transient ischemic attacks.","volume":"15","author":"Cujec","year":"1999","journal-title":"Can J Cardiol"},{"issue":"4","key":"noi200042r42","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/01.STR.25.4.782","article-title":"Patent foramen ovale and brain infarct: echocardiographic predictors, recurrence, and prevention.","volume":"25","author":"Hanna","year":"1994","journal-title":"Stroke"},{"issue":"4","key":"noi200042r43","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/0735-1097(95)00288-9","article-title":"Identification of patent foramen ovale permitting paradoxic embolism.","volume":"26","author":"Hausmann","year":"1995","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"noi200042r44","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/ccd.20868","article-title":"Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke.","volume":"68","author":"Thanopoulos","year":"2006","journal-title":"Catheter Cardiovasc Interv"},{"issue":"2","key":"noi200042r45","first-page":"94","article-title":"Comparison of medical treatments in cryptogenic stroke patients with patent foramen ovale: a randomized clinical trial.","volume":"18","author":"Shariat","year":"2013","journal-title":"J Res Med Sci"},{"issue":"5","key":"noi200042r46","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1212\/WNL.46.5.1301","article-title":"Stroke recurrence in patients with patent foramen ovale: the Lausanne Study.","volume":"46","author":"Bogousslavsky","year":"1996","journal-title":"Neurology"},{"issue":"7","key":"noi200042r47","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/0735-1097(94)90662-9","article-title":"Transesophageal echocardiography and carotid ultrasound in patients with cerebral ischemia: prevalence of findings and recurrent stroke risk.","volume":"23","author":"Comess","year":"1994","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"noi200042r48","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1161\/01.STR.31.10.2407","article-title":"Morphological and functional characteristics of patent foramen ovale and their embolic implications.","volume":"31","author":"De Castro","year":"2000","journal-title":"Stroke"},{"issue":"1","key":"noi200042r49","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.603","article-title":"Secondary prophylactic treatment and long-term prognosis after TIA and different subtypes of stroke: a 25-year follow-up hospital-based observational study.","volume":"7","author":"Eriksson","year":"2016","journal-title":"Brain Behav"},{"issue":"1","key":"noi200042r50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijcard.2010.10.032","article-title":"Low cerebrovascular event rate in subjects with patent foramen ovale and different clinical presentations: results from a prospective non randomized study on a population including patients with and without patent foramen ovale closure.","volume":"156","author":"Faggiano","year":"2012","journal-title":"Int J Cardiol"},{"issue":"6","key":"noi200042r51","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1536\/ihj.17-489","article-title":"RoPE score as a predictor of recurrent ischemic events after percutaneous patent foramen ovale closure.","volume":"59","author":"Morais","year":"2018","journal-title":"Int Heart J"},{"issue":"5","key":"noi200042r52","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3109\/07853890.2015.1057612","article-title":"Undetermined stroke with an embolic pattern\u2014a common phenotype with high early recurrence risk.","volume":"47","author":"Putaala","year":"2015","journal-title":"Ann Med"},{"issue":"1","key":"noi200042r53","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0002-8703(96)90065-4","article-title":"Patent foramen ovale: association between the degree of shunt by contrast transesophageal echocardiography and the risk of future ischemic neurologic events.","volume":"131","author":"Stone","year":"1996","journal-title":"Am Heart J"},{"key":"noi200042r54","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijcard.2015.05.088","article-title":"Recurrent stroke in patients with patent foramen ovale: an observational prospective study of percutaneous closure of PFO versus non-closure.","volume":"195","author":"Mirzada","year":"2015","journal-title":"Int J Cardiol"},{"issue":"8","key":"noi200042r55","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jcin.2014.01.170","article-title":"Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and\/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.","volume":"7","author":"Elmariah","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"noi200042r56","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1161\/STROKEAHA.113.000975","article-title":"PFO closure: CLOSURE.","volume":"44","author":"Furlan","year":"2013","journal-title":"Stroke"},{"issue":"9","key":"noi200042r57","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.003470","article-title":"Propensity score\u2013based analysis of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale: the IPSYS Registry (Italian Project on Stroke in Young Adults).","volume":"9","author":"Pezzini","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"issue":"22","key":"noi200042r58","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1161\/01.CIR.0000017498.88393.44","article-title":"Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study.","volume":"105","author":"Homma","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"noi200042r59","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/archinte.1991.00400050081016","article-title":"A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study.","volume":"151","author":"Anderson","year":"1991","journal-title":"Arch Intern Med"},{"issue":"1","key":"noi200042r60","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0025-6196(12)60336-X","article-title":"Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts.","volume":"59","author":"Hagen","year":"1984","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"noi200042r61","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1161\/STROKEAHA.117.018501","article-title":"Safety outcomes after percutaneous transcatheter closure of patent foramen ovale.","volume":"48","author":"Merkler","year":"2017","journal-title":"Stroke"},{"issue":"9958","key":"noi200042r62","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(14)60584-5","article-title":"Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials.","volume":"384","author":"Emberson","year":"2014","journal-title":"Lancet"},{"issue":"9413","key":"noi200042r63","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0140-6736(04)15785-1","article-title":"Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery.","volume":"363","author":"Rothwell","year":"2004","journal-title":"Lancet"},{"issue":"3","key":"noi200042r64","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.004152","article-title":"The case for selective patent foramen ovale closure after cryptogenic stroke.","volume":"11","author":"Wiktor","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"issue":"3","key":"noi200042r65","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jcmg.2013.12.011","article-title":"Accuracy of transcranial Doppler for the diagnosis of intracardiac right-to-left shunt: a bivariate meta-analysis of prospective studies.","volume":"7","author":"Mojadidi","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"noi200042r19","volume-title":"Generalised Linear Models","author":"McCullagh","year":"1979"},{"key":"noi200042r20","volume-title":"Essential Medical Statistics","author":"Kirkwood","year":"2003","edition":"2nd ed"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2767711\/jamaneurology_mazzucco_2020_oi_200042_1601489496.91877.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T18:50:01Z","timestamp":1602528601000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2767711"}},"subtitle":["A Population-Based Study and Systematic Review"],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":65,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2020.1948","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,1]]}}}